MetaCap

Belite Bio Balance Sheet

NASDAQ: BLTEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

154.49+1.97 (+1.29%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Belite Bio financial position

At the end of fiscal 2025, Belite Bio reported total assets of $780.6 million, up 413.1% from a year earlier against total liabilities of $10.1 million. Shareholders' equity stood at $770.5 million, or 98.7% of assets. The company held $352.9 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 50.02, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

Belite Bio balance sheet (annual)

Belite Bio annual balance sheet
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31
Cash & Equivalents352.93M31.68M88.16M42.09M17.34M25.62M
Short-Term Investments—4.55M————
Total Current Assets494.27M147.07M89.94M42.81M17.43M—
Property, Plant & Equipment344.00K444.00K490.00K541.00K94.00K—
Intangible Assets19.00K31.00K————
Total Assets780.56M152.13M94.64M44.27M18.35M—
Total Current Liabilities9.88M6.05M3.63M2.10M1.64M—
Total Liabilities10.07M6.31M4.21M2.77M1.64M—
Shareholders' Equity770.49M145.82M90.43M41.50M-15.09M-7.04M
Retained Earnings-185.26M-107.65M-71.50M-39.87M-27.22M-17.60M
Net Cash (Debt)352.93M36.23M88.16M42.09M17.34M25.62M
Shares Outstanding39.34M31.83M29.15M24.90M10.27M—

This table shows 6 annual periods of Belite Bio's balance sheet, from FY 2025 back to FY 2020, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow BLTE's reporting calendar. What is a balance sheet?

More financial data